Elsevier

Annals of Oncology

Volume 31, Supplement 4, September 2020, Pages S476-S477
Annals of Oncology

547P Rucaparib + sacituzumab govitecan (SG): Initial data from the phase Ib/II SEASTAR study (NCT03992131)

https://doi.org/10.1016/j.annonc.2020.08.661Get rights and content
Under an Elsevier user license
open archive

Cited by (0)